ArticleActa pharmaceutica Sinica. B2020

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells

Fanpu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.